Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis

Rhinology

Volumn 47, Issue 3, 2009, Pages 275-279

  Saitoh, Tatsuya ^a   Kusunoki, Takeshi ^a   Yao, Torn ^a   Kawano, Kenji ^a   Kojima, Yuko ^a   Miyahara, Katsumi ^a   Onoda, Junko ^a   Yokoi, Hidenori ^a   Ikeda, Katsuhisa ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Basement membrane thickness; Chronic rhinosinusitis; Epithelial damage; Nasal polyps

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; COMORBIDITY; EOSINOPHIL; HUMAN; IMMUNOHISTOCHEMISTRY; NOSE MUCOSA; NOSE POLYP; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RHINITIS; SINUSITIS;

BASEMENT MEMBRANE; COMORBIDITY; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 70349687427     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhin08.109     Document Type: Article

References (32)

1. Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003; 129: Sl-32.
2. Kaliner MA, Osguthorpe JD, Fireman P, Anon J, Georgitis J, Davis ML, Naclerio R, Kennedy D. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol. 1997; 99: S829-48.
3. Meltzer EO, Hamilos D, Hadley JA, Lanza DC, Bradley BF, Ncicklas RA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J All Clin Immunol. 2004; 114: S155-S212.
4. Fokkens W, Lund V, Mullol J et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007; 45 suppl. 20: 1-139.
5. Polzehl D, Moeller P, Riechelmann H, Perner S. Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy. 2006; 61:1275-1279.
6. van Zele T, Claeys S, Genaert P, van Maele G, Holtappels G, van Cauwenberge P, Bachert C. Differentiation of chronic sinus disease by measurement of inflammatory mediators. Allergy. 2006; 61: 1280-1289.
7. Eichel BS. A proposal for a staging system for hyperplastic rhinosinusitis based on the presence or absence of intranasal polyposis. Ear Nose Throat J. 1999; 78:262-265.
8. Georgitis JW, Matthews BL, Stone B. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid. Int Arch Allergy Immunol. 1995; 196: 416-421.
9. Suzuki H, Wataya H, Takahashi Y, Ikeda K, Shimomura A, Nakabayashi S, Takasaka T. Mechanism of neutrophil recruitment induced by interleukin-8 in chronic sinusitis. J Allergy Clin Immunol. 1996; 98: 659-670.
10. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 1997; 182:115-124.
11. Suzuki H, Ikeda K. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment. Current Drug Targets- Inflammation & Allergy. 2000; 1: 117-126.
12. Hamilos D, Leung DYM, Wood R, Meyers A, Stephens JK, Barkans J, Meng Q, Cunningham L, Bean DK, Kay AB, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte- macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol. 1993; 92: 39-48.
13. Ferguson BJ. Eosinophilic mucin rhinosinusitia: a distinct clinico- pathological entity. Laryngoscope. 2000; 110: 799-813.
14. Hamilos D. Chronic sinusitis. J Allergy Clin Immunol. 2000; 106: 213-227.
15. Steinke JW. The relationship between rhinosinusitis and asthma sinusitis. Curr Allergy Asthma Rep. 2006; 6: 495-501.
16. Slavin RG: Asthma and sinusitis. J Allergy Clin Immunol. 1992; 90: 534-537.
17. Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK, Yasruel Z, Schotman E, Hamid Q:Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol. 1995; 96: 537-544.
18. Naylor B. The shedding of the mucosa of the bronchial tree in asthma. Thorax. 1962; 17: 69-72.
19. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989; 1: 520-524.
20. Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE, Kita H.Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol. 2003; 112: 877-882.
21. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004; 4: 978-988
22. Tschumperlin DJ, Drazen JM. Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med. 2001; 164: S90-94.
23. Bucchieri F, Puddicombe SM, Lordan JL, Richter A, Buchanan D, Wilson SJ, Ward J, Zummo G, Howarth PH, Djukanović R, Holgate ST, Davies DE. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol. 2002; 27:179-185.
24. Trautmann A, Schmid-Grendelmeier P, Krüger K, Crameri R, Akdis M, Akkaya A, Bröcker EB, Blaser K, Akdis CA. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol. 2002; 109: 329-337.
25. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM, Saetta M. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med. 2006; 174: 975-981.
26. Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc. 2004; 1: 93-98.
27. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J, Harley CB, Gauldie J, Jordana M. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest. 1992; 89:1662-1668.
28. Thomas DC, Wormald PJ. Standardization of diagnostic criteria for eosinophilic chronic rhinosinusitis in the Oestrus ovis infected sheep model. Am J Rhinol. 2007; 21: 551-555.
29. Wei JL, Kita H, Sherris DA, Kern EB, Waver A, Ponikau JU: The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope. 2003; 113: 303-306.
30. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993; 44: 85-101.
31. Locksley RM, Wilson CB, Klebanoff SJ. Role for endogenous and acquired peroxidase in the toxoplasamacidal activity of murine and human mononuclear phagocytes. J Clin Invest. 1982; 69:1099-1111.
32. Nonaka M, Pawankar R, Saji F, Yagi T. Distinct expression of RANTES and GM-CSF by Lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol. 1999; 119:314-321.